Cargando…

Clinical features and metabolic complications for non-alcoholic fatty liver disease (NAFLD) in youth with obesity

Pediatric obesity has become in the last forty years the most common metabolic disease in children and adolescents affecting about 25% of the pediatric population in the western world. As obesity worsens, a whole-body insulin resistance (IR) occurs. This phenomenon is more pronounced during adolesce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barbieri, Emiliano, Santoro, Nicola, Umano, Giuseppina Rosaria
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9887046/ https://www.ncbi.nlm.nih.gov/pubmed/36733529 http://dx.doi.org/10.3389/fendo.2023.1062341

Ejemplares similares

From the liver to the heart: Cardiac dysfunction in obese children with non-alcoholic fatty liver disease
por: Di Sessa, Anna, et al.
Publicado: (2017)

The Association between Pediatric NAFLD and Common Genetic Variants
por: Umano, Giuseppina Rosaria, et al.
Publicado: (2017)

Comparison of Metabolic Response to Colonic Fermentation in Lean Youth vs Youth With Obesity
por: Galuppo, Brittany, et al.
Publicado: (2023)

Is Metabolic Syndrome Useful for Identifying Youths with Obesity at Risk for NAFLD?
por: Di Bonito, Procolo, et al.
Publicado: (2023)

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD)
por: Rong, Li, et al.
Publicado: (2023)

Metabolic Features of Nonalcoholic Fatty Liver (NAFL) in Obese Adolescents: Findings From a Multiethnic Cohort
por: Tricò, Domenico, et al.
Publicado: (2018)

Growth differentiation factor 15 (GDF15) is associated with non-alcoholic fatty liver disease (NAFLD) in youth with overweight or obesity
por: Galuppo, Brittany, et al.
Publicado: (2022)

Non-Alcoholic Fatty Liver Disease in Obese Youth With Insulin Resistance and Type 2 Diabetes
por: Scapaticci, Serena, et al.
Publicado: (2021)

Fatty liver index predicts incident risk of prediabetes, type 2 diabetes and non-alcoholic fatty liver disease (NAFLD)
por: Cuthbertson, Daniel J., et al.
Publicado: (2021)

Editorial: The roles and mechanisms of hepatokines, adipokines and myokines in the development of non-alcoholic fatty liver disease (NAFLD)
por: Lu, Yan
Publicado: (2022)

The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children
por: Di Sessa, Anna, et al.
Publicado: (2017)

Prediabetes in youth – mechanisms and biomarkers
por: Weiss, Ram, et al.
Publicado: (2017)

Effect of Gut Microbiota and PNPLA3 rs738409 Variant on Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Youth
por: Monga Kravetz, Ayesha, et al.
Publicado: (2020)

Circulating levels of DLK1 and glucose homeostasis in girls with obesity: A pilot study
por: Palumbo, Stefania, et al.
Publicado: (2022)

THU586 Lipid Species In Non-alcoholic Fatty Liver Disease (NAFLD) In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Identification of biomarkers for the diagnosis of chronic kidney disease (CKD) with non-alcoholic fatty liver disease (NAFLD) by bioinformatics analysis and machine learning
por: Cao, Yang, et al.
Publicado: (2023)

The Troubling Link Between Non-alcoholic Fatty Liver Disease (NAFLD) and Extrahepatic Cancers (EHC)
por: Venniyoor, Ajit, et al.
Publicado: (2021)

Thyroid Function and the Risk of Non-Alcoholic Fatty Liver Disease in Morbid Obesity
por: Borges-Canha, Marta, et al.
Publicado: (2020)

THU585 Non-alcoholic Fatty Liver Disease (NAFLD), A Silent But Emerging Problem In Type 1 Diabetes
por: Taiwo, Adeyinka, et al.
Publicado: (2023)

Genetic Evaluation of Patients With Delayed Puberty and Congenital Hypogonadotropic Hypogonadism: Is it Worthy of Consideration?
por: Festa, Adalgisa, et al.
Publicado: (2020)

Discussing the role of circular RNA in the pathogenesis of non-alcoholic fatty liver disease and its complications
por: Yepmo, Melissa, et al.
Publicado: (2022)

Insights from shotgun metagenomics into bacterial species and metabolic pathways associated with NAFLD in obese youth
por: Testerman, Todd, et al.
Publicado: (2022)

Lower Circulating Leptin Levels Are Related to Non-Alcoholic Fatty Liver Disease in Children With Obesity
por: Brandt, Stephanie, et al.
Publicado: (2022)

Obesity, non-alcoholic fatty liver disease and hepatocellular carcinoma: current status and therapeutic targets
por: Chen, Yinshuang, et al.
Publicado: (2023)

Macrophages and scavenger receptors in obesity‐associated non‐alcoholic liver fatty disease (NAFLD)
por: Kragh Petersen, Sine, et al.
Publicado: (2020)

Role of Innate Immune Response in Non-Alcoholic Fatty Liver Disease: Metabolic Complications and Therapeutic Tools
por: Meli, Rosaria, et al.
Publicado: (2014)

Endotoxins and Non-Alcoholic Fatty Liver Disease
por: Kessoku, Takaomi, et al.
Publicado: (2021)

RF32 | PSUN44 CARF Regulates Non-Alcoholic Fatty Liver Diseases (NAFLD) by Controlling ER Stress and Lipogenesis in Hepatic Cells.
por: Friedman, Theodore, et al.
Publicado: (2022)

Connection of Nicotine to Diet-Induced Obesity and Non-Alcoholic Fatty Liver Disease: Cellular and Mechanistic Insights
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2017)

Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach
por: Romero-Ibarguengoitia, Maria Elena, et al.
Publicado: (2018)

Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Independent Risk Factor for Developing New-Onset Diabetes After Acute Pancreatitis: A Multicenter Retrospective Cohort Study in Chinese Population
por: Lv, Yingqi, et al.
Publicado: (2022)

Abdominal obesity and dsyglycemia are risk factors for liver fibrosis progression in NAFLD subjects: A population-based study
por: Julián, María Teresa, et al.
Publicado: (2023)

Non-alcoholic fatty liver disease (Nafld) in obese children- effect of refined carbohydrates in diet
por: Félix, Deise Rosa, et al.
Publicado: (2016)

Can Diet Help Non-Obese Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)?
por: Merchant, Hamid A.
Publicado: (2017)

Gut Dysfunction and Non-alcoholic Fatty Liver Disease
por: Grabherr, Felix, et al.
Publicado: (2019)

Nutrition and Obesity in the Pathogenesis of Youth-Onset Type 1 Diabetes and Its Complications
por: March, Christine A., et al.
Publicado: (2021)

Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
por: Jeong, Seogsong, et al.
Publicado: (2023)

Editorial: Obesity, Smoking, and Fatty Liver Disease
por: Sinha-Hikim, Amiya P., et al.
Publicado: (2018)

Correction: Family history and obesity in youth, their effect on acylcarnitine/aminoacids metabolomics and non-alcoholic fatty liver disease (NAFLD). Structural equation modeling approach
por: Romero-Ibarguengoitia, Maria Elena, et al.
Publicado: (2018)

Recommendations for the management of non-alcoholic fatty liver disease (NAFLD)
por: Tomasiewicz, Krzysztof, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_bjfs0jafuvddpgi8ackigr34rm